 | • レポートコード：QFJ1-4950 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、アフェレシス療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療用血漿交換、赤血球交換）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アフェレシス療法の市場動向 ・企業の競争状況、市場シェア ・アフェレシス療法の種類別市場規模と予測2016-2027（治療用血漿交換、赤血球交換） ・アフェレシス療法の用途別市場規模と予測2016-2027（病院、診療所、その他） ・アフェレシス療法の北米市場規模2016-2027（アメリカ、カナダ） ・アフェレシス療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アフェレシス療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アフェレシス療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・アフェレシス療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Miltenyi Biotec、Fresenius、Terumo、Baxter、Medica Group） ・結論 |
Therapeutic apheresis is a procedure of the removal of a blood component from a patient using the apheresis technology. Therapeutic apheresis is used for the purpose of removing defective cells. Therapeutic apheresis is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.
Market Analysis and Insights: Global Therapeutic Apheresis Market
The global Therapeutic Apheresis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Apheresis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Apheresis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Apheresis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Apheresis market.
Global Therapeutic Apheresis Scope and Market Size
Therapeutic Apheresis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Apheresis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Therapeutic Plasma Exchange
Red Blood Cell Exchange
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Miltenyi Biotec
Fresenius
Terumo
Baxter
Medica Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Apheresis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutic Plasma Exchange
1.2.3 Red Blood Cell Exchange
1.3 Market by Application
1.3.1 Global Therapeutic Apheresis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Apheresis Market Perspective (2016-2027)
2.2 Therapeutic Apheresis Growth Trends by Regions
2.2.1 Therapeutic Apheresis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Therapeutic Apheresis Historic Market Share by Regions (2016-2021)
2.2.3 Therapeutic Apheresis Forecasted Market Size by Regions (2022-2027)
2.3 Therapeutic Apheresis Industry Dynamic
2.3.1 Therapeutic Apheresis Market Trends
2.3.2 Therapeutic Apheresis Market Drivers
2.3.3 Therapeutic Apheresis Market Challenges
2.3.4 Therapeutic Apheresis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Apheresis Players by Revenue
3.1.1 Global Top Therapeutic Apheresis Players by Revenue (2016-2021)
3.1.2 Global Therapeutic Apheresis Revenue Market Share by Players (2016-2021)
3.2 Global Therapeutic Apheresis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Apheresis Revenue
3.4 Global Therapeutic Apheresis Market Concentration Ratio
3.4.1 Global Therapeutic Apheresis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Apheresis Revenue in 2020
3.5 Therapeutic Apheresis Key Players Head office and Area Served
3.6 Key Players Therapeutic Apheresis Product Solution and Service
3.7 Date of Enter into Therapeutic Apheresis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Apheresis Breakdown Data by Type
4.1 Global Therapeutic Apheresis Historic Market Size by Type (2016-2021)
4.2 Global Therapeutic Apheresis Forecasted Market Size by Type (2022-2027)
5 Therapeutic Apheresis Breakdown Data by Application
5.1 Global Therapeutic Apheresis Historic Market Size by Application (2016-2021)
5.2 Global Therapeutic Apheresis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Therapeutic Apheresis Market Size (2016-2027)
6.2 North America Therapeutic Apheresis Market Size by Type
6.2.1 North America Therapeutic Apheresis Market Size by Type (2016-2021)
6.2.2 North America Therapeutic Apheresis Market Size by Type (2022-2027)
6.2.3 North America Therapeutic Apheresis Market Size by Type (2016-2027)
6.3 North America Therapeutic Apheresis Market Size by Application
6.3.1 North America Therapeutic Apheresis Market Size by Application (2016-2021)
6.3.2 North America Therapeutic Apheresis Market Size by Application (2022-2027)
6.3.3 North America Therapeutic Apheresis Market Size by Application (2016-2027)
6.4 North America Therapeutic Apheresis Market Size by Country
6.4.1 North America Therapeutic Apheresis Market Size by Country (2016-2021)
6.4.2 North America Therapeutic Apheresis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Therapeutic Apheresis Market Size (2016-2027)
7.2 Europe Therapeutic Apheresis Market Size by Type
7.2.1 Europe Therapeutic Apheresis Market Size by Type (2016-2021)
7.2.2 Europe Therapeutic Apheresis Market Size by Type (2022-2027)
7.2.3 Europe Therapeutic Apheresis Market Size by Type (2016-2027)
7.3 Europe Therapeutic Apheresis Market Size by Application
7.3.1 Europe Therapeutic Apheresis Market Size by Application (2016-2021)
7.3.2 Europe Therapeutic Apheresis Market Size by Application (2022-2027)
7.3.3 Europe Therapeutic Apheresis Market Size by Application (2016-2027)
7.4 Europe Therapeutic Apheresis Market Size by Country
7.4.1 Europe Therapeutic Apheresis Market Size by Country (2016-2021)
7.4.2 Europe Therapeutic Apheresis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Apheresis Market Size (2016-2027)
8.2 Asia-Pacific Therapeutic Apheresis Market Size by Type
8.2.1 Asia-Pacific Therapeutic Apheresis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Therapeutic Apheresis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Therapeutic Apheresis Market Size by Type (2016-2027)
8.3 Asia-Pacific Therapeutic Apheresis Market Size by Application
8.3.1 Asia-Pacific Therapeutic Apheresis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Therapeutic Apheresis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Therapeutic Apheresis Market Size by Application (2016-2027)
8.4 Asia-Pacific Therapeutic Apheresis Market Size by Region
8.4.1 Asia-Pacific Therapeutic Apheresis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Therapeutic Apheresis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Therapeutic Apheresis Market Size (2016-2027)
9.2 Latin America Therapeutic Apheresis Market Size by Type
9.2.1 Latin America Therapeutic Apheresis Market Size by Type (2016-2021)
9.2.2 Latin America Therapeutic Apheresis Market Size by Type (2022-2027)
9.2.3 Latin America Therapeutic Apheresis Market Size by Type (2016-2027)
9.3 Latin America Therapeutic Apheresis Market Size by Application
9.3.1 Latin America Therapeutic Apheresis Market Size by Application (2016-2021)
9.3.2 Latin America Therapeutic Apheresis Market Size by Application (2022-2027)
9.3.3 Latin America Therapeutic Apheresis Market Size by Application (2016-2027)
9.4 Latin America Therapeutic Apheresis Market Size by Country
9.4.1 Latin America Therapeutic Apheresis Market Size by Country (2016-2021)
9.4.2 Latin America Therapeutic Apheresis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Apheresis Market Size (2016-2027)
10.2 Middle East & Africa Therapeutic Apheresis Market Size by Type
10.2.1 Middle East & Africa Therapeutic Apheresis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Therapeutic Apheresis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Therapeutic Apheresis Market Size by Type (2016-2027)
10.3 Middle East & Africa Therapeutic Apheresis Market Size by Application
10.3.1 Middle East & Africa Therapeutic Apheresis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Therapeutic Apheresis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Therapeutic Apheresis Market Size by Application (2016-2027)
10.4 Middle East & Africa Therapeutic Apheresis Market Size by Country
10.4.1 Middle East & Africa Therapeutic Apheresis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Therapeutic Apheresis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Miltenyi Biotec
11.1.1 Miltenyi Biotec Company Details
11.1.2 Miltenyi Biotec Business Overview
11.1.3 Miltenyi Biotec Therapeutic Apheresis Introduction
11.1.4 Miltenyi Biotec Revenue in Therapeutic Apheresis Business (2016-2021)
11.1.5 Miltenyi Biotec Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Details
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Therapeutic Apheresis Introduction
11.2.4 Fresenius Revenue in Therapeutic Apheresis Business (2016-2021)
11.2.5 Fresenius Recent Development
11.3 Terumo
11.3.1 Terumo Company Details
11.3.2 Terumo Business Overview
11.3.3 Terumo Therapeutic Apheresis Introduction
11.3.4 Terumo Revenue in Therapeutic Apheresis Business (2016-2021)
11.3.5 Terumo Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Therapeutic Apheresis Introduction
11.4.4 Baxter Revenue in Therapeutic Apheresis Business (2016-2021)
11.4.5 Baxter Recent Development
11.5 Medica Group
11.5.1 Medica Group Company Details
11.5.2 Medica Group Business Overview
11.5.3 Medica Group Therapeutic Apheresis Introduction
11.5.4 Medica Group Revenue in Therapeutic Apheresis Business (2016-2021)
11.5.5 Medica Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Therapeutic Apheresis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutic Plasma Exchange
Table 3. Key Players of Red Blood Cell Exchange
Table 4. Global Therapeutic Apheresis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Therapeutic Apheresis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Therapeutic Apheresis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Therapeutic Apheresis Market Share by Regions (2016-2021)
Table 8. Global Therapeutic Apheresis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Therapeutic Apheresis Market Share by Regions (2022-2027)
Table 10. Therapeutic Apheresis Market Trends
Table 11. Therapeutic Apheresis Market Drivers
Table 12. Therapeutic Apheresis Market Challenges
Table 13. Therapeutic Apheresis Market Restraints
Table 14. Global Therapeutic Apheresis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Therapeutic Apheresis Market Share by Players (2016-2021)
Table 16. Global Top Therapeutic Apheresis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Apheresis as of 2020)
Table 17. Ranking of Global Top Therapeutic Apheresis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Therapeutic Apheresis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Therapeutic Apheresis Product Solution and Service
Table 21. Date of Enter into Therapeutic Apheresis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Therapeutic Apheresis Revenue Market Share by Type (2016-2021)
Table 25. Global Therapeutic Apheresis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Therapeutic Apheresis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Therapeutic Apheresis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Therapeutic Apheresis Revenue Market Share by Application (2016-2021)
Table 29. Global Therapeutic Apheresis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Therapeutic Apheresis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Therapeutic Apheresis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Therapeutic Apheresis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Therapeutic Apheresis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Therapeutic Apheresis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Therapeutic Apheresis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Therapeutic Apheresis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Therapeutic Apheresis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Therapeutic Apheresis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Therapeutic Apheresis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Therapeutic Apheresis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Therapeutic Apheresis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Therapeutic Apheresis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Therapeutic Apheresis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Therapeutic Apheresis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Therapeutic Apheresis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Therapeutic Apheresis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Therapeutic Apheresis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Therapeutic Apheresis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Therapeutic Apheresis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Therapeutic Apheresis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Therapeutic Apheresis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Therapeutic Apheresis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Therapeutic Apheresis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Therapeutic Apheresis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Therapeutic Apheresis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Therapeutic Apheresis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Miltenyi Biotec Company Details
Table 62. Miltenyi Biotec Business Overview
Table 63. Miltenyi Biotec Therapeutic Apheresis Product
Table 64. Miltenyi Biotec Revenue in Therapeutic Apheresis Business (2016-2021) & (US$ Million)
Table 65. Miltenyi Biotec Recent Development
Table 66. Fresenius Company Details
Table 67. Fresenius Business Overview
Table 68. Fresenius Therapeutic Apheresis Product
Table 69. Fresenius Revenue in Therapeutic Apheresis Business (2016-2021) & (US$ Million)
Table 70. Fresenius Recent Development
Table 71. Terumo Company Details
Table 72. Terumo Business Overview
Table 73. Terumo Therapeutic Apheresis Product
Table 74. Terumo Revenue in Therapeutic Apheresis Business (2016-2021) & (US$ Million)
Table 75. Terumo Recent Development
Table 76. Baxter Company Details
Table 77. Baxter Business Overview
Table 78. Baxter Therapeutic Apheresis Product
Table 79. Baxter Revenue in Therapeutic Apheresis Business (2016-2021) & (US$ Million)
Table 80. Baxter Recent Development
Table 81. Medica Group Company Details
Table 82. Medica Group Business Overview
Table 83. Medica Group Therapeutic Apheresis Product
Table 84. Medica Group Revenue in Therapeutic Apheresis Business (2016-2021) & (US$ Million)
Table 85. Medica Group Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Apheresis Market Share by Type: 2020 VS 2027
Figure 2. Therapeutic Plasma Exchange Features
Figure 3. Red Blood Cell Exchange Features
Figure 4. Global Therapeutic Apheresis Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Therapeutic Apheresis Report Years Considered
Figure 9. Global Therapeutic Apheresis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Therapeutic Apheresis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Therapeutic Apheresis Market Share by Regions: 2020 VS 2027
Figure 12. Global Therapeutic Apheresis Market Share by Regions (2022-2027)
Figure 13. Global Therapeutic Apheresis Market Share by Players in 2020
Figure 14. Global Top Therapeutic Apheresis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Apheresis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Therapeutic Apheresis Revenue in 2020
Figure 16. Global Therapeutic Apheresis Revenue Market Share by Type (2016-2021)
Figure 17. Global Therapeutic Apheresis Revenue Market Share by Type (2022-2027)
Figure 18. North America Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Therapeutic Apheresis Market Share by Type (2016-2027)
Figure 20. North America Therapeutic Apheresis Market Share by Application (2016-2027)
Figure 21. North America Therapeutic Apheresis Market Share by Country (2016-2027)
Figure 22. United States Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Therapeutic Apheresis Market Share by Type (2016-2027)
Figure 26. Europe Therapeutic Apheresis Market Share by Application (2016-2027)
Figure 27. Europe Therapeutic Apheresis Market Share by Country (2016-2027)
Figure 28. Germany Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Therapeutic Apheresis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Therapeutic Apheresis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Therapeutic Apheresis Market Share by Region (2016-2027)
Figure 38. China Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Therapeutic Apheresis Market Share by Type (2016-2027)
Figure 46. Latin America Therapeutic Apheresis Market Share by Application (2016-2027)
Figure 47. Latin America Therapeutic Apheresis Market Share by Country (2016-2027)
Figure 48. Mexico Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Therapeutic Apheresis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Therapeutic Apheresis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Therapeutic Apheresis Market Share by Country (2016-2027)
Figure 54. Turkey Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Therapeutic Apheresis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Miltenyi Biotec Revenue Growth Rate in Therapeutic Apheresis Business (2016-2021)
Figure 58. Fresenius Revenue Growth Rate in Therapeutic Apheresis Business (2016-2021)
Figure 59. Terumo Revenue Growth Rate in Therapeutic Apheresis Business (2016-2021)
Figure 60. Baxter Revenue Growth Rate in Therapeutic Apheresis Business (2016-2021)
Figure 61. Medica Group Revenue Growth Rate in Therapeutic Apheresis Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
アフェレーシス機器のグローバル市場2021 Apheresis machine is a device which receives blood removed from a patient or donor’s body and separates it into its various components: plasma, platelets, white blood cells and red blood cells. Depending on the reason for apheresis, one of these components is isolated and collected by the instrument…- 世界のリンパ芽球性リンパ腫治療市場規模・現状・予測（2021年-2027年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- アフェレーシス装置のグローバル市場2021 Apheresis is an invasive process that involves the separation of components such as platelets, RBC, plasma, and other components from whole blood. In this procedure, the blood of a donor or a patient is passed through an apheresis machine or a blood cell separator. Currently, The industry is highly …
- 世界のマゴットセラピー市場規模・現状・予測（2021年-2027年） Maggot therapy is a type of biotherapy involving the introduction of live, disinfected maggots (fly larvae) into the non-healing skin and soft tissue wound(s) of a human or animal for the purpose of cleaning out the necrotic (dead) tissue within a wound (debridement) and disinfection. North America …
- 世界の寄生虫病治療市場規模・現状・予測（2021年-2027年） Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria. Market Analysis and Insights: Global Parasitic Diseases Therapeutic Market The global Parasitic Diseases Therapeutic market size is projected to reach US$ XX mill…